Arcadia Biosciences, Inc. – NASDAQ:RKDA
Arcadia Biosciences stock price today
$4.46
-1.65
-27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Arcadia Biosciences stock price monthly change
+89.16%
month
Arcadia Biosciences stock price quarterly change
+89.16%
quarter
Arcadia Biosciences stock price yearly change
+114.39%
year
Arcadia Biosciences key metrics
Market Cap | 8.68M |
Enterprise value | N/A |
P/E | -0.28 |
EV/Sales | -0.84 |
EV/EBITDA | 0.63 |
Price/Sales | 0.24 |
Price/Book | 0.20 |
PEG ratio | N/A |
EPS | -5.29 |
Revenue | 5.41M |
EBITDA | -17.22M |
Income | -7.02M |
Revenue Q/Q | -16.83% |
Revenue Y/Y | -34.37% |
Profit margin | -138.79% |
Oper. margin | -159.8% |
Gross margin | 1.92% |
EBIT margin | -159.8% |
EBITDA margin | -318.37% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeArcadia Biosciences stock price history
Arcadia Biosciences stock forecast
Arcadia Biosciences financial statements
| Jun 2023 | 1.38M | 823K | 59.25% |
|---|---|---|---|
| Sep 2023 | 1.59M | -2.56M | -160.74% |
| Dec 2023 | 1.17M | -2.85M | -243.85% |
| Mar 2024 | 1.25M | -2.42M | -193.07% |
| Mar 2024 | 1.25M | -2.42M | -193.07% |
|---|---|---|---|
| Sep 2025 | 2.5M | -1.20M | -48.33% |
| Oct 2025 | 1.8M | -646.78K | -35.93% |
| Dec 2025 | 1.7M | -660.40K | -38.85% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 26798000 | 9.06M | 33.84% |
|---|---|---|---|
| Sep 2023 | 23466000 | 8.06M | 34.38% |
| Dec 2023 | 19705000 | 7.00M | 35.53% |
| Mar 2024 | 16046000 | 5.56M | 34.67% |
| Jun 2023 | -4.79M | -4.71M | 0 |
|---|---|---|---|
| Sep 2023 | -2.88M | 5K | 7K |
| Dec 2023 | -4.14M | 52K | -84.75M |
| Mar 2024 | -3.21M | 4K | 5K |
Arcadia Biosciences alternative data
| Aug 2023 | 30 |
|---|---|
| Sep 2023 | 30 |
| Oct 2023 | 30 |
| Nov 2023 | 30 |
| Dec 2023 | 30 |
| Jan 2024 | 30 |
| Feb 2024 | 30 |
| Mar 2024 | 30 |
| Apr 2024 | 30 |
| May 2024 | 21 |
| Jun 2024 | 21 |
| Jul 2024 | 21 |
Arcadia Biosciences other data
26.31%
+16.67%
of RKDA is owned by hedge funds
3.94K
-55.23K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 5000 | 0 |
| Aug 2023 | 649 | 0 |
| Feb 2024 | 700 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SCHAEFER THOMAS J. officer: Chief Financial Officer | Common Stock | 700 | $2.06 | $1,442 | ||
Purchase | SCHAEFER THOMAS J. officer: Chief Financial Officer | Common Stock | 649 | $3.67 | $2,382 | ||
Purchase | JACOT STANLEY JR officer: Chief Executive Officer | Common stock | 5,000 | $4.31 | $21,550 | ||
Purchase | SCHAEFER THOMAS J. officer: Chief Financial Officer | Common Stock | 700 | $0.23 | $161 | ||
Purchase | HALEY PAMELA officer: Chief Fi.. | Common Stock | 700 | $0.7 | $490 | ||
Purchase | PLAVAN MATTHEW T officer: Chief Executive Officer | Common Stock | 585 | N/A | N/A | ||
Purchase | SHULTZ RANDALL officer: Chief Technology Officer | Common Stock | 700 | N/A | N/A | ||
Purchase | HALEY PAMELA officer: Chief Fi.. | Common Stock | 700 | N/A | N/A | ||
Purchase | HALEY PAMELA officer: Chief Fi.. | Common Stock | 700 | N/A | N/A | ||
Purchase | REITER SARAH officer: Chief Commercial Officer | Common Stock | 700 | N/A | N/A |
| Patent |
|---|
Application Filling date: 13 Aug 2021 Issue date: 10 Feb 2022 |
Grant Filling date: 12 Mar 2020 Issue date: 21 Dec 2021 |
Grant Filling date: 15 Oct 2019 Issue date: 14 Sep 2021 |
Application Filling date: 12 Jan 2021 Issue date: 6 May 2021 |
Grant Filling date: 7 Mar 2018 Issue date: 2 Mar 2021 |
Application Wheat Having Resistance to Glyphosate Due to Alterations in 5-Enol-Pyruvylshikimate-3 Phosphate Synthase Filling date: 15 Sep 2020 Issue date: 4 Feb 2021 |
Application Filling date: 7 Oct 2020 Issue date: 28 Jan 2021 |
Grant Filling date: 9 Sep 2019 Issue date: 10 Nov 2020 |
Grant Utility: Wheat having resistance to glyphosate DUe to alterations in 5-enol-pyruvylshikimate-3 phosphate synthase Filling date: 1 Jul 2016 Issue date: 13 Oct 2020 |
Application Filling date: 5 Jun 2020 Issue date: 24 Sep 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Arcadia Biosciences stock today?
One share of Arcadia Biosciences stock can currently be purchased for approximately $4.46.
-
When is Arcadia Biosciences's next earnings date?
Unfortunately, Arcadia Biosciences's (RKDA) next earnings date is currently unknown.
-
Does Arcadia Biosciences pay dividends?
No, Arcadia Biosciences does not pay dividends.
-
How much money does Arcadia Biosciences make?
Arcadia Biosciences has a market capitalization of 8.68M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 46.46% to 5.33M US dollars.
-
What is Arcadia Biosciences's stock symbol?
Arcadia Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "RKDA".
-
What is Arcadia Biosciences's primary industry?
Company operates in the Basic Materials sector and Agricultural Inputs industry.
-
How do i buy shares of Arcadia Biosciences?
Shares of Arcadia Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Arcadia Biosciences's key executives?
Arcadia Biosciences's management team includes the following people:
- Ms. Pamela Haley Chief Financial Officer & Corporation Sec.(age: 54, pay: $271,800)
- Mr. Kevin J. Comcowich Chairman & Interim Chief Executive Officer(age: 56, pay: $90,500)
-
How many employees does Arcadia Biosciences have?
As Jul 2024, Arcadia Biosciences employs 21 workers, which is 30% less then previous quarter.
-
When Arcadia Biosciences went public?
Arcadia Biosciences, Inc. is publicly traded company for more then 10 years since IPO on 15 May 2015.
-
What is Arcadia Biosciences's official website?
The official website for Arcadia Biosciences is arcadiabio.com.
-
Where are Arcadia Biosciences's headquarters?
Arcadia Biosciences is headquartered at 202 Cousteau Place, Davis, CA.
-
How can i contact Arcadia Biosciences?
Arcadia Biosciences's mailing address is 202 Cousteau Place, Davis, CA and company can be reached via phone at +53 7 567077.
Arcadia Biosciences company profile:
Arcadia Biosciences, Inc.
arcadiabio.comExchange:
NASDAQ
Full time employees:
21
Industry:
Agricultural Inputs
Sector:
Basic Materials
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
202 Cousteau Place
Davis, CA 95618
Davis, CA 95618
CIK: 0001469443
ISIN: US0390143032
CUSIP: 039014204
